5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications

Fan Yao1, Ming Zhang1, Li Chen2

  • 1Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.

Insights

AMPK activation of autophagy may treat diabetes and its complications. This review explores how AMPK stimulates autophagy, offering a promising therapeutic target for metabolic homeostasis in diabetes mellitus.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Cellular Biology

Background:

  • Diabetes mellitus (DM) is a growing global health concern, projected to be a leading cause of death.
  • Cellular injury and metabolic dysregulation are central to DM pathogenesis and complications.
  • Autophagy, a cellular degradation process, is increasingly recognized for its role in DM.

Purpose of the Study:

  • To review the regulation of autophagy and AMPK in diabetes and its complications.
  • To explore the mechanisms by which AMPK stimulates autophagy in diabetic conditions.
  • To highlight AMPK as a potential therapeutic target for managing diabetes.

Main Methods:

  • Literature review focusing on autophagy, AMPK, and diabetes.
  • Analysis of studies investigating AMPK's role in autophagy regulation.
  • Synthesis of current research on AMPK-mediated autophagy in diabetic syndromes.

Main Results:

  • AMP-activated protein kinase (AMPK) is crucial for maintaining metabolic homeostasis.
  • AMPK activation stimulates autophagy, a process that clears damaged cellular components.
  • Autophagy plays a significant role in both the development and progression of diabetes and its complications.

Conclusions:

  • AMPK-mediated autophagy is a key pathway in managing diabetes.
  • Understanding AMPK's regulation of autophagy offers a promising therapeutic strategy for diabetes treatment.
  • Targeting AMPK-autophagy axis could mitigate diabetic complications and improve metabolic health.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.5K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K